• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; LLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; LLD Back to Search Results
Model Number 518-019
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Iatrogenic Source (2498); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 01/14/2019
Event Type  Injury  
Manufacturer Narrative
Patient age and weight were unavailable from the physician.Device model number, lot number, unique device identifier, and expiration date are not available from the facility.The device was discarded by the user.Device 510k cannot be determined without the model#.Device manufacture date is dependent on the device lot number, thus is unavailable.The device was discarded.There is no allegation of a malfunction.Therefore, no device evaluation will be performed.
 
Event Description
A philips representative reported that a cardiac lead management procedure commenced due to bacteremia and cardiac implantable electronic device (cied) pocket infection.The physician utilized the spectranetics sls laser sheath and spectranetics lead locking device (lld) to remove the right ventricular (rv) pacing lead.He stopped 1.5 cm before the end of the tip of the lead where there was still tissue to be removed.He applied gentle traction to the lld, keeping the sls laser sheath in place, but without activating the spectranetics cvx-300 excimer laser system foot switch.After 30 seconds the lead came out with a small peace of pericardial tissue of about 2 mm visible on the tip of the lld.The transesophageal echocardiogram (tee) showed a pericardial effusion.Rescue interventions were implemented and successful.The patient was brought back to a stable state and was discharged a few days later.
 
Manufacturer Narrative
Device model#, lot#, di # and expiration date now provided.Model numbers of pacing leads provided.510k now provided.Device manufactured date now provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRANETICS LEAD LOCKING DEVICE
Type of Device
LLD
Manufacturer (Section D)
THE SPECTRANETICS CORPORATION
9965 federal drive
colorado springs CO 80921
MDR Report Key8386464
MDR Text Key137697641
Report Number1721279-2019-00027
Device Sequence Number1
Product Code DRB
Combination Product (y/n)Y
PMA/PMN Number
K990713
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/01/2005,02/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/12/2020
Device Model Number518-019
Device Catalogue Number518-019
Device Lot NumberFLC18K04A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received03/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BIOTRONIK AROX 60BP LEAD.; BIOTRONIK SELOX SR53.; PACING LEAD (MFR UNKNOWN).; SPECTRANETICS CVX-300 EXCIMER LASER SYSTEM.; SPECTRANETICS SLS LASER SHEATH.; PACING LEAD (MFR UNKNOWN); SPECTRANETICS CVX-300 EXCIMER LASER SYSTEM; SPECTRANETICS SLS LASER SHEATH
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-